The "Acromegaly - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Acromegaly Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Acromegaly.
The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 API manufacturer details by country. Coverage of API manufacturers for Acromegaly marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.
This report provides a comprehensive understanding of the emerging Phase III therapies for Acromegaly which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.
Key Topics Covered:
1. Report Introduction
2. Acromegaly: Overview
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed Therapies
5. Emerging Therapies (Phase III)
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/7bvfbq/acromegaly?w=4.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180828005815/en/
Contacts:
ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs